Risks of blood transfusion

被引:133
作者
Goodnough, LT
机构
[1] Washington Univ, Barnes Jewish Hosp, Dept Med, St Louis, MO USA
[2] Washington Univ, Barnes Jewish Hosp, Dept Pathol, St Louis, MO USA
[3] Washington Univ, Barnes Jewish Hosp, Dept Immunol, St Louis, MO USA
关键词
blood transfusion; blood risks; leukoreduction; transfusion-related immunomodulation; transfusion-transmitted infections;
D O I
10.1097/01.CCM.0000100124.50579.D9
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To review the current status of risks of blood transfusion. Data Sources, Extractions, and Synthesis., English-speaking literature, literature search using key works, human data, and follow-up with key bibliographic citations. Conclusions. Substantial advances have been achieved in blood safety during the last 20 yrs, particularly for transfusion-transmitted viral infections. Currently, the most serious known risks from blood transfusion are administrative error (leading to ABO-incompatible blood transfusion), transfusion-related acute lung injury, and bacterial contamination in platelet products. Emerging pathogens, such as West Nile virus infection emphasize the need for implementation of proactive strategies, such as pathogen inactivation technologies, as well as reactive strategies, such as nucleic acid testing, to ensure continued advances in blood safety.
引用
收藏
页码:S678 / S686
页数:9
相关论文
共 124 条
[41]   Transfusion medicine: looking to the future [J].
Goodnough, LT ;
Shander, A ;
Brecher, ME .
LANCET, 2003, 361 (9352) :161-169
[42]   PREVALENCE OF PLATELET TRANSFUSION REACTIONS BEFORE AND AFTER IMPLEMENTATION OF LEUKOCYTE-DEPLETED PLATELET CONCENTRATES BY FILTRATION [J].
GOODNOUGH, LT ;
RIDDELL, J ;
LAZARUS, H ;
CHAFEL, TL ;
PRINCE, G ;
HENDRIX, D ;
YOMTOVIAN, R .
VOX SANGUINIS, 1993, 65 (02) :103-107
[43]   The case against universal WBC reduction (and for the practice of evidence-based medicine) [J].
Goodnough, LT .
TRANSFUSION, 2000, 40 (12) :1522-1527
[44]   Medical progress - Transfusion medicine (First of two parts) - Blood transfusion [J].
Goodnough, LT ;
Brecher, ME ;
Kanter, MH ;
AuBuchon, JP .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (06) :438-447
[45]  
Goodnough LT, 1998, J CLIN APHERESIS, V13, P114, DOI 10.1002/(SICI)1098-1101(1998)13:3<114::AID-JCA4>3.3.CO
[46]  
2-Y
[47]   RAPID DEVELOPMENT OF MYELOPATHY AFTER HTLV-I INFECTION ACQUIRED BY TRANSFUSION DURING CARDIAC TRANSPLANTATION [J].
GOUT, O ;
BAULAC, M ;
GESSAIN, A ;
SEMAH, F ;
SAAL, F ;
PERIES, J ;
CABROL, C ;
FOUCAULTFRETZ, C ;
LAPLANE, D ;
SIGAUX, F ;
DETHE, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (06) :383-388
[48]   TRANSFUSION MALARIA IN THE UNITED-STATES, 1972-1981 [J].
GUERRERO, IC ;
WENIGER, BC ;
SCHULTZ, MG .
ANNALS OF INTERNAL MEDICINE, 1983, 99 (02) :221-226
[49]   RISK STRATIFICATION USING THE SOCIETY-OF-THORACIC-SURGEONS PROGRAM [J].
HATTLER, BG ;
MADIA, C ;
JOHNSON, C ;
ARMITAGE, JM ;
HARDESTY, RL ;
KORMOS, RL ;
PHAM, SM ;
PAYNE, DN ;
GRIFFITH, BP .
ANNALS OF THORACIC SURGERY, 1994, 58 (05) :1348-1352
[50]  
HEBERT PC, 2003, JAMA-J AM MED ASSOC, V289, P1993